Mabion

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership

From Research to Release: Mapping Mabion’s Full Analytical Lifecycle for Monoclonal Antibodies 

Analytics, Mabion, Monoclonal antibody

The New Era of Biosimilar Development: Seizing the Opportunity Under EMA’s Streamlined Guidelines

Biosimilars, Clinical trials, Drug development, EMA, FDA, Mabion, Regulatory

Does Your CDMO Have An Analytical Edge?

Analytics, Biosimilars, Mabion

Quality as the Basis for CDMO Partnership Success

GMP, Mabion

The Benefits of Outsourcing Your Biomanufacturing to a Polish CDMO

Mabion

Four Steps To Identifying The CDMO Proposal Worth Signing

Mabion

A synergy of excellence: Novavax-Mabion partnership on vaccine during unprecedented times amid the COVID-19 pandemic

Mabion, Vaccines